Japan lists Bharat Biotech’s Covaxin as recognized COVID-19 vaccine

The Indian Embassy in Japan informed the development on Twitter.

On Thursday, April 7, the government of Japan has listed India’s indigenously made Covaxin as a recognised vaccine. Covaxin is developed by Bharat Biotech.

The Indian Embassy in Japan informed the development on Twitter. “Government of Japan includes the indigenously developed and manufactured COVID-19 vaccine Covaxin by Bharat Biotech of India, as one of the recognised vaccines for 1st and 2nd dose with effect from 10 April 2022 to further facilitate travel from India to Japan,” tweeted the embassy.

The World Health Organisation (WHO) has recently halted the supply & procurement of Covaxin citing some issues at the company’s facility. WHO has further recommended the countries that are using Covaxin to “take actions as appropriate.”

Bharat Biotech has said that appropriate action will be taken to resolve the issues soon. The company has also slowed down its production after WHO’s statement but the recognition by Japan can be good news for the company.

 

Subscribe to our newsletter
Subscribe to our newsletter
Sign up here to get the latest news delivered directly to your inbox.
You can unsubscribe at any time